A detailed history of Verition Fund Management LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 15,510 shares of NEO stock, worth $218,535. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,510
Holding current value
$218,535
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.4 - $17.73 $207,834 - $274,992
15,510 New
15,510 $228,000
Q1 2024

May 14, 2024

BUY
$14.06 - $16.79 $142,990 - $170,754
10,170 New
10,170 $159,000
Q3 2023

Nov 14, 2023

BUY
$12.15 - $17.85 $257,883 - $378,866
21,225 New
21,225 $261,000
Q1 2023

May 15, 2023

BUY
$9.09 - $19.45 $202,661 - $433,637
22,295 New
22,295 $388,000
Q3 2022

Nov 14, 2022

BUY
$7.86 - $12.91 $113,577 - $186,549
14,450 New
14,450 $124,000
Q2 2022

Aug 15, 2022

SELL
$7.06 - $13.97 $113,334 - $224,260
-16,053 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$12.15 - $35.28 $195,043 - $566,349
16,053 New
16,053 $195,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.77B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.